Skip to main content
WeRide Inc. logo

WeRide Inc. — Investor Relations & Filings

Ticker · 800 LEI · 254900R1B7IWBCPDQ262 HKEX Transportation and storage
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2002-11-20 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 800

About WeRide Inc.

http://www.weride.ai

WeRide Inc. is a commercial-stage global technology leader specializing in the research, development, and large-scale deployment of autonomous driving solutions, ranging from Level 2 (WePilot 3.0 ADAS) to Level 4 capabilities. The company offers a comprehensive portfolio of autonomous vehicles designed for various mobility and logistics applications, including Robotaxi, Robobus, Robovan, and Robosweeper. WeRide is recognized as a pioneer in the industry, operating in over 40 cities across 11 countries and holding autonomous driving permits in seven countries globally. Its core products, such as the Robotaxi, have launched large-scale commercial operations in regions like China and the UAE. WeRide leverages its proprietary technology stack to deliver safe, reliable, and scalable driverless solutions for urban transformation.

Recent filings

Filing Released Lang Actions
Exceptional Turnover Movement
Regulatory Filings Classification · 98% confidence The document is a short announcement issued by Far East Pharmaceutical Technology Company Limited in response to a request from the Stock Exchange of Hong Kong regarding unusual trading volume. It confirms that the company is not aware of any price-sensitive information or undisclosed negotiations. Since it is a general regulatory announcement regarding market activity that does not fit into specific categories like M&A or financial reports, it falls under the RNS (Regulatory Filings) category.
2002-11-20 English
Annual Report
Report Publication Announcement Classification · 95% confidence The document is a landing page or index for the 2002 Annual Report of Far East Pharmaceutical Technology Company Limited. It provides a list of hyperlinks to various sections of the report (e.g., Chairman's Statement, Financial Statements, etc.) rather than containing the actual financial data itself. Per the 'Menu vs Meal' rule, this is an announcement or index of a report publication, not the report itself. FY 2002
2002-11-01 English
Circular (General Mandates to Repurchase Shares and Warrants and to Issue New Shares)
Share Issue/Capital Change Classification · 95% confidence The document is a circular addressed to shareholders regarding the granting of general mandates to repurchase shares and warrants and to issue new shares. It discusses resolutions to be proposed at the forthcoming Annual General Meeting (AGM) and provides detailed explanatory statements about the buyback mandate and issuance mandate. It includes proxy arrangements for the AGM and recommendations from the board. The document is not a report of financial results, audit, or earnings, nor is it a transcript or legal proceeding. It is a communication related to shareholder voting and meeting materials, specifically about share repurchase and issuance mandates to be voted on at the AGM. This fits the category of Share Issue/Capital Change (SHA) because it concerns share repurchase and issuance mandates. The document length and content indicate it is the actual circular, not just an announcement of a report. Therefore, the appropriate classification is SHA with high confidence.
2002-10-31 English
Notices of General Meetings
AGM Information Classification · 95% confidence The document is titled 'NOTICE OF ANNUAL GENERAL MEETING' and details the agenda for the AGM of Far East Pharmaceutical Technology Company Limited, including receiving and considering audited financial statements, dividend declaration, re-election of directors, appointment of auditors, and approval of share purchase and issuance mandates. It is a notice announcing the meeting and the business to be conducted, not the actual meeting materials or presentations. The document length is 8047 characters, which is consistent with a detailed notice but not a full report or presentation. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including notices of the meeting and agenda items.
2002-10-22 English
Results Announcement
Annual Report Classification · 95% confidence The document is titled 'ANNOUNCEMENT OF FINAL RESULTS FOR THE YEAR ENDED 30 JUNE 2002' and contains detailed audited consolidated annual financial results, including income statement, segment information, profit from operating activities, taxation, dividends, earnings per share, and a business and financial review. The content includes comprehensive financial data and analysis for the full fiscal year ending 30 June 2002, with comparative figures for the previous year. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement or summary. The presence of audited annual results and detailed financial statements aligns with the definition of an Annual Report (10-K). Therefore, the document should be classified as an Annual Report (10-K).
2002-10-22 English
Results Announcement (Summary)
Earnings Release Classification · 98% confidence The document is a 'Results Announcement' from Far East Pharmaceutical Technology Company Limited. It provides a summary of financial performance (turnover, profit, EPS) for the fiscal year ending 30/6/2002, including comparative data, dividend information, and accounting policy notes. While it contains financial data, it is structured as an initial announcement of results rather than a full 10-K annual report or a standalone audit report. In the context of stock exchange filings, this is classified as an Earnings Release (ER). FY 2002
2002-10-21 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.